Get started
TATVA CHINTAN PHARMA CHEM LIMITATVA CHINTAN PHARMA CHEM LIMITATVA CHINTAN PHARMA CHEM LIMI

TATVA CHINTAN PHARMA CHEM LIMI

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

TATVA chart


Full chart

TATVA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪17.13 B‬ INR
Dividend yield (indicated)
0.28%
Price to earnings Ratio (TTM)
119.85
Basic EPS (TTM)
6.10 INR
Net income (FY)
‪303.54 M‬ INR
Revenue (FY)
‪3.93 B‬ INR
Shares float
‪6.55 M‬
Beta (1Y)
0.97

Employees


Employees (FY)
925
Change (1Y)
+38 +4.28%
Revenue / Employee (1Y)
‪4.25 M‬ INR
Net income / Employee (1Y)
‪328.15 K‬ INR

About TATVA CHIN PHARM CHEM LTD


Sector
Process Industries
Industry
Chemicals: Specialty
CEO
Chintan Nitinkumar Shah
Website
tatvachintan.com
Headquarters
Vadodara
Founded
1996
ISIN
INE0GK401011
FIGI
BBG011RKXW05
Tatva Chintan Pharma Chem Ltd. is a chemicals manufacturing company. The firm is engaged in the manufacture of portfolio, which includes structure directing agents(SDAs), phase transfer catalysts(PTCs), electrolyte salts for super capacitor batteries, and pharmaceutical and agrochemical intermediates and other specialty chemicals(PASC). The company was founded on June 12, 1996 and is headquartered in Vadodara, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

TATVA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as TATVA.

Frequently Asked Questions


The current price of TATVA is 742.50 INR — it has increased by 1.37% in the past 24 hours. Watch TATVA CHINTAN PHARMA CHEM LIMI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange TATVA CHINTAN PHARMA CHEM LIMI stocks are traded under the ticker TATVA.
TATVA stock has risen by 6.83% compared to the previous week, the month change is a 8.35% rise, over the last year TATVA CHINTAN PHARMA CHEM LIMI has showed a −39.47% decrease.
We've gathered analysts' opinions on TATVA CHINTAN PHARMA CHEM LIMI future price: according to them, TATVA price has a max estimate of 1,220.00 INR and a min estimate of 585.00 INR. Watch TATVA chart and read a more detailed TATVA CHINTAN PHARMA CHEM LIMI stock forecast: see what analysts think of TATVA CHINTAN PHARMA CHEM LIMI and suggest that you do with its stocks.
TATVA reached its all-time high on Nov 3, 2021 with the price of 2,975.55 INR, and its all-time low was 610.00 INR and was reached on Apr 7, 2025. View more price dynamics on TATVA chart.
See other stocks reaching their highest and lowest prices.
TATVA stock is 2.48% volatile and has beta coefficient of 0.97. Track TATVA CHINTAN PHARMA CHEM LIMI stock price on the chart and check out the list of the most volatile stocks — is TATVA CHINTAN PHARMA CHEM LIMI there?
Today TATVA CHINTAN PHARMA CHEM LIMI has the market capitalization of ‪17.13 B‬, it has increased by 9.35% over the last week.
Yes, you can track TATVA CHINTAN PHARMA CHEM LIMI financials in yearly and quarterly reports right on TradingView.
TATVA CHINTAN PHARMA CHEM LIMI is going to release the next earnings report on May 2, 2025. Keep track of upcoming events with our Earnings Calendar.
TATVA earnings for the last quarter are 0.10 INR per share, whereas the estimation was −0.20 INR resulting in a 150.00% surprise. The estimated earnings for the next quarter are 2.20 INR per share. See more details about TATVA CHINTAN PHARMA CHEM LIMI earnings.
TATVA CHINTAN PHARMA CHEM LIMI revenue for the last quarter amounts to ‪859.00 M‬ INR, despite the estimated figure of ‪887.25 M‬ INR. In the next quarter, revenue is expected to reach ‪1.04 B‬ INR.
TATVA net income for the last quarter is ‪1.38 M‬ INR, while the quarter before that showed ‪−6.64 M‬ INR of net income which accounts for 120.78% change. Track more TATVA CHINTAN PHARMA CHEM LIMI financial stats to get the full picture.
Yes, TATVA dividends are paid annually. The last dividend per share was 2.00 INR. As of today, Dividend Yield (TTM)% is 0.27%. Tracking TATVA CHINTAN PHARMA CHEM LIMI dividends might help you take more informed decisions.
TATVA CHINTAN PHARMA CHEM LIMI dividend yield was 0.19% in 2023, and payout ratio reached 15.08%. The year before the numbers were 0.12% and 9.75% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 22, 2025, the company has 925 employees. See our rating of the largest employees — is TATVA CHINTAN PHARMA CHEM LIMI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TATVA CHINTAN PHARMA CHEM LIMI EBITDA is ‪408.71 M‬ INR, and current EBITDA margin is 17.26%. See more stats in TATVA CHINTAN PHARMA CHEM LIMI financial statements.
Like other stocks, TATVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TATVA CHINTAN PHARMA CHEM LIMI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TATVA CHINTAN PHARMA CHEM LIMI technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TATVA CHINTAN PHARMA CHEM LIMI stock shows the sell signal. See more of TATVA CHINTAN PHARMA CHEM LIMI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.